US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

FUNDX FUTURE FUND OPPORTUNITIES ETF

29.03

+0.28180.98%

Volume:1K

Turnover:30.65K

Market Cap:232.68M

PE:- -

High:29.04

Open:29.03

Low:29.03

Close:28.75

52wk High:31.30

52wk Low:25.44

Shares:8.02M

Float Shares:8.02M

Volume Ratio:0.26

T/O Rate:0.01%

Dividend:0.49

Dividend Rate:1.70%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Twinstrand: Court Preserves 2023 Willful Infringement Verdict & Orders 6% Royalty on Sales of 11 Guardant Health Products & Services

THOMSON REUTERS

Halozyme Director Dannielle Appelhans Files Initial Beneficial Ownership Statement

Halozyme CEO Helen Torley Sells USD 4.13 Million in Common Shares

Soccer-Sheffield United's Ex-Owners Winds up Company Which Bought Club

Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2

Halozyme Appoints COUR Pharma CEO Dannielle Appelhans to Board

Halozyme Appoints Dannielle Appelhans to Its Board of Directors

THOMSON REUTERS

Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test

Simply Wall St.

Sagtec announces commercial launch of HALO AI Food-Serving Robot

Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Halozyme Director Bernadette Connaughton Disposes of 1.626 Shares Worth $167.152,8

Federal Reserve's diluted forward guidance fails to curb rate hike expectations, markets await July CPI for next rate path clues

What Halozyme Therapeutics (HALO) Guidance Raise Means For Valuation

Simply Wall St.

Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan

Bullion Rebounds Rely on Rate Path Evaluation

Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?

Simply Wall St.

RBC Capital Remains a Buy on GH Research (GHRS)

Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)

Halozyme price target raised to $105 from $93 at Morgan Stanley

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/FFOX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"FFOX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFOX\",,,,,undefined,":{"symbol":"FFOX","market":"US","secType":"STK","nameCN":"FUNDX FUTURE FUND OPPORTUNITIES ETF","latestPrice":29.03,"timestamp":1788359663087,"preClose":28.7482,"halted":0,"volume":1056,"delay":0,"changeRate":0.00980235284296062,"floatShares":8015000,"shares":8015000,"eps":0,"marketStatus":"Trading","change":0.2818,"latestTime":"09-02 10:47:17 EDT","open":29.03,"high":29.04,"low":29.03,"amount":30648.027168,"amplitude":0.000348,"askPrice":29.03,"askSize":4300,"bidPrice":28.99,"bidSize":2300,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"exchange":"ARCA","adjPreClose":28.7482,"sharesOutstanding":7155000,"nav":29.26,"aum":235396700,"dividendRate":0.017044,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":28.82,"preClose":28.7482,"latestTime":"16:10 EDT","volume":6,"amount":172.4892,"timestamp":1788293404223,"change":0.0718,"changeRate":0.002498,"amplitude":0},"volumeRatio":0.261705},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FFOX\",,,,,undefined,":{"symbol":"FFOX","floatShares":8015000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.261705,"shares":8015000,"dividePrice":0.4948,"high":29.04,"amplitude":0.000348,"preClose":28.7482,"low":29.03,"week52Low":25.44,"pbRate":"--","week52High":31.295,"institutionHeld":0,"latestPrice":29.03,"committee":-0.30303,"eps":0,"divideRate":0.017044,"volume":1056,"delay":0,"ttmEps":0,"open":29.03,"prevYearClose":27.27,"prevWeekClose":29.4519,"prevMonthClose":29.2799,"prevQuarterClose":30.29,"fiveDayClose":30.12,"twentyDayClose":30.31,"sixtyDayClose":28},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FFOX\",params:#limit:5,,,undefined,":[{"date":"2025-12-31","symbol":"FFOX","amount":0.49447507,"announcedDate":"2025-12-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"FUNDX FUTURE FUND OPPORTUNITIES ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-02","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-01-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FFOX\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-31","recordDate":"2025-12-31","paymentDate":"2026-01-02","value":0.49447507,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FFOX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FFOX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661273336","title":"Twinstrand: Court Preserves 2023 Willful Infringement Verdict & Orders 6% Royalty on Sales of 11 Guardant Health Products & Services","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273336","media":"THOMSON REUTERS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273336?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:00","pubTimestamp":1787569200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nP8N3M60G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","GNMX","GDOC","LU0109394709.USD","GH","LFSC","PTH","LU0889565916.HKD","BK4551","BK4535","BK4588","EKG","FFOX","LU0320765992.SGD","GNOM","BK4196","HELX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661290328","title":"Halozyme Director Dannielle Appelhans Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2661290328","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661290328?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:56","pubTimestamp":1787345761,"startTime":"0","endTime":"0","summary":"Halozyme director Dannielle Appelhans files initial beneficial ownership statementHalozyme filed a Form 3 naming Dannielle Appelhans as a director in an initial statement of beneficial ownership dated","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL2XH0zN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","BK4139","FFOX","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660647907","title":"Halozyme CEO Helen Torley Sells USD 4.13 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2660647907","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660647907?lang=en_us&edition=fundamental","pubTime":"2026-08-20 08:01","pubTimestamp":1787184117,"startTime":"0","endTime":"0","summary":"Halozyme CEO Helen Torley sells USD 4.13 million in common sharesHalozyme: President and CEO Helen Torley exercised options for 60,000 common shares at $18.41 on Aug. 17-19, 2026.She sold 59,000 commo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL1hJtYF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Halozyme CEO Helen Torley Sells USD 4.13 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","FFOX","BK4139","HALO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660428271","title":"Soccer-Sheffield United's Ex-Owners Winds up Company Which Bought Club","url":"https://stock-news.laohu8.com/highlight/detail?id=2660428271","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660428271?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:22","pubTimestamp":1787142120,"startTime":"0","endTime":"0","summary":"Soccer-Sheffield United's ex-owners winds up company which bought clubLONDON, Aug 19 (Reuters)-Sheffield United's former owner on Wednesday won a bid to wind up the company that in 2024 bought the sec","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL1N44F0P9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EKG","LU0889565916.HKD","PTH","BK4535","BK4551","LFSC","BK4196","BK4585","BK4588","FFOX","GDOC","GNOM","GH","HELX","GNMX","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660970474","title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2","url":"https://stock-news.laohu8.com/highlight/detail?id=2660970474","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660970474?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:15","pubTimestamp":1787091347,"startTime":"0","endTime":"0","summary":"Guardant Health director Tariq Musa disposes of 116 common shares worth $18,148.2Guardant Health director Tariq Musa sold 116 common shares on Aug. 17 at USD 156.45.The sale cut his directly held stak","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLbdy8Tn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Director Tariq Musa Disposes of 116 Common Shares Worth $18,148.2","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GH","LU0889565916.HKD","PTH","BK4535","LU0320765992.SGD","BK4551","FFOX","GDOC","GNOM","LFSC","GNMX","LU0109394709.USD","BK4585","HELX","EKG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660130494","title":"Halozyme Appoints COUR Pharma CEO Dannielle Appelhans to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2660130494","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660130494?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:01","pubTimestamp":1787083301,"startTime":"0","endTime":"0","summary":"Halozyme appoints COUR Pharma CEO Dannielle Appelhans to boardHalozyme elected Dannielle Appelhans to its board of directors.Appelhans has been CEO of COUR Pharmaceuticals since 2023, leading a Genent","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDLb9PQN8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","HALO","FFOX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494188","title":"Halozyme Appoints Dannielle Appelhans to Its Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494188","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494188?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:01","pubTimestamp":1787083260,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nTUA77ZWP3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["HALO","BK4139","FFOX","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660495332","title":"Guardant Health (GH) Back In Focus As New Approvals Put Valuation To The Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2660495332","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660495332?lang=en_us&edition=fundamental","pubTime":"2026-08-18 21:26","pubTimestamp":1787059570,"startTime":"0","endTime":"0","summary":"Why Guardant Health Stock Is Back on Investors’ Radar\nGuardant Health (GH) moved into focus after several Q2 2026 developments, including FDA approval of an updated Guardant360 liquid biopsy test and new American Cancer Society support for its Shield colorectal cancer screening.\nThese clinical and guideline milestones arrived alongside stronger than expected Q1 results related to test volume and coverage trends. This provided investors with fresh information on how the company’s product...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-back-in-focus-as-new-approvals-put-valuat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-back-in-focus-as-new-approvals-put-valuat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","BK4196","BK4588","GH","BK4551","EKG","GNOM","LU0109394709.USD","GDOC","LU0889565916.HKD","LFSC","BK4535","GNMX","HELX","PTH","LU0320765992.SGD","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660467049","title":"Sagtec announces commercial launch of HALO AI Food-Serving Robot","url":"https://stock-news.laohu8.com/highlight/detail?id=2660467049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660467049?lang=en_us&edition=fundamental","pubTime":"2026-08-18 20:50","pubTimestamp":1787057414,"startTime":"0","endTime":"0","summary":"Sagtec (SAGT) announced the official commercial launch of its HALO AI Food-Serving Robot, together with the received a purchase order for 1,500 uni...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagtec-announces-commercial-launch-of-halo-ai-food-serving-robot-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagtec-announces-commercial-launch-of-halo-ai-food-serving-robot-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARTY","VTHR","AGIX","BK4023","AIPO","SAGT","FFOX","HALO","LU0053671581.USD","QTOC","BK4139","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659719596","title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659719596","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659719596?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:21","pubTimestamp":1786663307,"startTime":"0","endTime":"0","summary":"Guardant Health Chief People Officer Terilyn Monroe disposes of common shares worth $7.61 millionGuardant Health Chief People Officer Terilyn J. Monroe cut her direct common stock stake to 22,979 shar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1rsYJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4588","BK4551","LU0109394709.USD","HELX","BK4535","LU0320765992.SGD","GNMX","PTH","EKG","GDOC","BK4196","GH","BK4585","FFOX","LFSC","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949165","title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949165","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949165?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:23","pubTimestamp":1786487005,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Commercial Officer Chris Freeman disposes of $ 10.75 million in common sharesGuardant Health Chief Commercial Officer Chris Freeman exercised stock options for 63,605 shares on A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4khYKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LFSC","GDOC","GNMX","BK4551","LU0109394709.USD","FFOX","LU0889565916.HKD","PTH","EKG","BK4196","BK4588","GNOM","HELX","LU0320765992.SGD","BK4585","GH","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946085","title":"Halozyme Director Bernadette Connaughton Disposes of 1.626 Shares Worth $167.152,8","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946085","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658946085?lang=en_us&edition=fundamental","pubTime":"2026-08-12 05:44","pubTimestamp":1786484679,"startTime":"0","endTime":"0","summary":"Halozyme director Bernadette Connaughton disposes of 1.626 shares worth $167.152,8Direktur Bernadette Connaughton menjual 1.626 saham common stock Halozyme Therapeutics pada 10 Agustus 2026.Transaksi ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL5qqdsL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Halozyme Director Bernadette Connaughton Disposes of 1.626 Shares Worth $167.152,8","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HALO","LU0053671581.USD","FFOX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186040777","title":"Federal Reserve's diluted forward guidance fails to curb rate hike expectations, markets await July CPI for next rate path clues","url":"https://stock-news.laohu8.com/highlight/detail?id=1186040777","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186040777?lang=en_us&edition=fundamental","pubTime":"2026-08-11 10:55","pubTimestamp":1786416951,"startTime":"0","endTime":"0","summary":"The Federal Reserve Chair Kevin Warsh is reshaping the central bank's communication strategy, softening traditional forward guidance and reducing explicit hints about future interest rate paths....","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEI","KDRN","MFSB","VCSH","SSO","TBT","DVVY","JULD","TXXI","UUP","EDV","UBmain","AGG","SPUU","HK0000934320.USD","LQD","WAMA","EVNT","XBOX","BUYO","XBIL","HIBL","LIAJ","LQID","EMPB","NUAG","ZROZ","XTEN","IBHJ","TLTI","OOQB","THRV","FEM","JPST","SPY","HMOP","DMAX","FLGV","SKRE","TBJL","DFLV","GOVT","VFH","NGHT","ESmain","SGOV","VEXC","HYG","MESmain","KBE","SHY","BK4535","CGUI","FFOX","PAYH","VGIT","VGLT","BWZ","BWX","SECR","XLF","MUB","BKLN","US30Y.BOND","TUA","IVV","VCIT","DPST","SPXU","US2Y.BOND","BSV","EVG","BBSB","IBTJ","US5Y.BOND","MINT","UDN","EBUF","SPYB","MUNX","VSHY","BUCK","US10Y.BOND","BBIB","SPYH","GBIL","FNK","BOXX","US7Y.BOND","BBLB","KBWB","BK4585","TYO","GOLY","TAXX","NELS","BK4504","BOND","BK4561",".SPX","BND","IAT","ZBmain","TIP","BK4559","IGOV","YSPY","UBT","GMOC","IBCE","PFLD","SCHO","US12M.BOND","IEF","TLH","US3Y.BOND","ZFmain","KRX","TMF","BCFN","SPXS","ZTmain","ISHG","QSWN","SPYU","TBIL","SLWS","SHV","RAUS","SPYQ","US6M.BOND","TSYW","XLRI","TLT","PBDC","TFJL","JUCY","BIV","JFLX","NEMD","JAAA","FITZ","KRE","SPXL","FAZ","BIL","TLTX","BK4550","OEX","SPDN","FNCL","SROI","SH","BK4588","CIK","TNmain","VOO","TLTW","DBND","SMAX","MMAX","UPRO","SDS","SPYM","AGZD","USHY","BK4581","VGSH","SCYB","SPYI","MYCN","BK4534","CIVG","QMY","OEF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658963135","title":"What Halozyme Therapeutics (HALO) Guidance Raise Means For Valuation","url":"https://stock-news.laohu8.com/highlight/detail?id=2658963135","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658963135?lang=en_us&edition=fundamental","pubTime":"2026-08-11 08:40","pubTimestamp":1786408844,"startTime":"0","endTime":"0","summary":"Earnings, guidance and new deals put Halozyme Therapeutics in focus\nHalozyme Therapeutics (HALO) drew fresh attention after reporting second quarter revenue of US$481 million and net income of US$229.91 million, along with higher full year revenue guidance and new ENHANZE collaboration agreements.\nSee our latest analysis for Halozyme Therapeutics.\nThe latest earnings, higher 2026 revenue guidance and accelerated buybacks appear to have supported momentum in Halozyme Therapeutics, with a 30...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-halo/halozyme-therapeutics/news/what-halozyme-therapeutics-halo-guidance-raise-means-for-val","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-halo/halozyme-therapeutics/news/what-halozyme-therapeutics-halo-guidance-raise-means-for-val","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FFOX","LU0053671581.USD","HALO","BK4139","DCF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658599689","title":"Guardant Health Grants 46,044 RSUs to 149 New Employees Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2658599689","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658599689?lang=en_us&edition=fundamental","pubTime":"2026-08-11 04:13","pubTimestamp":1786392812,"startTime":"0","endTime":"0","summary":"Guardant Health grants 46,044 RSUs to 149 new employees under inducement planGuardant Health set inducement RSU grants covering 46,044 common shares for 149 new non-executive hires, with an Aug. 3, 20","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nNDL208d3j:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GNOM","HELX","BK4196","BK4535","BK4585","EKG","FFOX","BK4551","GH","LU0109394709.USD","PTH","GNMX","GDOC","LFSC","LU0889565916.HKD","BK4588","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114783192","title":"Bullion Rebounds Rely on Rate Path Evaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=1114783192","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1114783192?lang=en_us&edition=fundamental","pubTime":"2026-08-10 16:51","pubTimestamp":1786351884,"startTime":"0","endTime":"0","summary":"Following weaker-than-expected employment data on August 10, gold and silver rallied in tandem as declining yields and a softer US dollar eased short-term valuation pressures on precious metals. This...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BKLN","FNK","BUCK","SCYB","TAXX","GMOC","FITZ","KDRN","THRV","FFOX","SROI","EVG","ZSL","BCFN","CIK","DVVY","PFLD","CGUI","DFLV","EVNT","JFLX","TXXI","BK4588","FNCL","SLV","IBHJ","BUYO","MFSB","SECR","IBCE","SIVR","SLWS","VSHY","BK4585","PAYH","QMY","AGQ","JAAA","LQID","NUAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658660616","title":"Is GH Research’s Rising Loss Per Share Reframing the GHRS Cash Burn Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2658660616","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658660616?lang=en_us&edition=fundamental","pubTime":"2026-08-10 07:38","pubTimestamp":1786318701,"startTime":"0","endTime":"0","summary":"GH Research PLC recently reported second-quarter 2026 results showing a net loss of US$15.15 million, up from US$9.29 million a year earlier, with basic and diluted loss per share from continuing operations rising to US$0.23 from US$0.15.\nFor the first half of 2026, the company’s net loss expanded to US$34.11 million versus US$20.10 million in the prior-year period, highlighting a meaningful increase in cash burn and pressure on its financial profile.\nWe’ll now examine how this widening net...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/is-gh-researchs-rising-loss-per-share-reframing-the-ghrs-cas","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ghrs/gh-research/news/is-gh-researchs-rising-loss-per-share-reframing-the-ghrs-cas","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GNOM","HELX","BK4585","FFOX","LU0109394709.USD","LFSC","LU0889565916.HKD","LU0320765992.SGD","BK4539","PTH","BK4007","PSIL","EKG","BK4551","GH","GHRS","BK4588","BK4196","BK4535","GNMX","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657229326","title":"RBC Capital Remains a Buy on GH Research (GHRS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657229326","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657229326?lang=en_us&edition=fundamental","pubTime":"2026-08-08 09:45","pubTimestamp":1786153544,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Buy rating on GH Research on August 6 and set a price target of $42.00. The company’s shares closed...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-gh-research-ghrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-remains-a-buy-on-gh-research-ghrs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4196","BK4007","LU0029864427.USD","PTH","GHRS","GNOM","GH","BK4585","LU1267930573.SGD","BK4551","EKG","GNMX","LFSC","FFOX","LU0320765992.SGD","BK4588","PSIL","LU0708994859.HKD","BK4207","BK4535","LU0310800379.SGD","LU0889565916.HKD","GDOC","GSIB","LU0128525929.USD","HELX","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657260426","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: InMode (INMD), GH Research (GHRS) and Scholar Rock Holding (SRRK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657260426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657260426?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:30","pubTimestamp":1786134613,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on InMode (INMD), GH Research (GHRS) and Scholar Rock...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-inmode-inmd-gh-research-ghrs-and-scholar-rock-holding-srrk-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBRN","XLV","BK4551","LU0029874061.USD","BK4585","HCSG","LU0889565916.HKD","SRRK","BK4007","HELX","EKG","GNOM","PSIL","INMD","LU0109394709.USD","GDOC","BK4139","GNMX","BK4082","GHRS","LABU","BK4535","BK4539","LU0128526141.USD","FFOX","BK4588","THNR","BK4581","BK4196","LU0320765992.SGD","PTH","GH","LFSC","XBI","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657649006","title":"Halozyme price target raised to $105 from $93 at Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2657649006","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657649006?lang=en_us&edition=fundamental","pubTime":"2026-08-07 21:41","pubTimestamp":1786110082,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Sean Laaman raised the firm’s price target on Halozyme (HALO) to $105 from $93 and keeps an Overweight rating on the shares....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/halozyme-price-target-raised-to-105-from-93-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/halozyme-price-target-raised-to-105-from-93-at-morgan-stanley-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFOX","HALO","BK4139","LU0053671581.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":70,"code":"91000000","status":"200"}]}}